DJIA 17,191.37 -195.84 -1.13%
NASDAQ 4,637.99 -43.50 -0.93%
S&P 500 2,002.16 -27.39 -1.35%
market minute promo

1.61 -0.12 (-6.94%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NAVB $1.61 -6.94%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.75
Previous Close $1.73
Daily Range $1.60 - $1.77
52-Week Range $0.97 - $2.12
Market Cap $242.7M
P/E Ratio -5.97
Dividend (Yield) $0.00 (0.0%)
Volume 709,105
Average Daily Volume 1,169,595
Current FY EPS -$0.21

Sector

Healthcare

Industry

Healthcare Information Services

Navidea Biopharmaceuticals, Inc. (NAVB) Description

Neoprobe Corporation is a biomedical company which is engaged in the development and commercialization of innovative surgical and diagnostic products that enhance patient care by meeting the critical decision making needs of physicians. Website: http://www.navidea.com/

News & Commentary Rss Feed

This Week in Biotech: Actions Speak Louder Than Words

Regulatory actions provided the impetus to big moves for these five biotech stocks.

Seeking Alpha's Biotech Weekly: Salix Sale Murmurs, A Very Active CHMP, And More

Navidea Pharmaceuticals: An Update On My $2 Biotech Lottery Ticket

Can the Rally in Navidea (NAVB) Shares Continue? - Tale of the Tape

Macrophage Therapy Is Navidea's Value Driver

European Commission Approves Navidea's Sentinel Lymph Node Detection Agent Lymphoseek

Navidea Biopharmaceuticals (NAVB) Jumps: Stock Up 7.8% - Tale of the Tape

Sector Update: Health Care Stocks Generally Higher Pre-Bell

Sector Update: Health Care

Navidea Receives $1.1M PDUFA Filing Fee Refund For Award Of Orphan Drug Status; Platinum Partners Re

Navidea Receives $1.1M PDUFA Filing Fee Refund For Award Of Orphan Drug Status; Platinum Partners Reaffirms Commitment To Line Of Credit

Navidea Biopharmaceuticals, Inc's (NAVB) CEO Rick Gonzalez on Q3 2014 Results - Earnings Call Transc

Navidea Biopharmaceuticals, Inc's (NAVB) CEO Rick Gonzalez on Q3 2014 Results - Earnings Call Transcript

See More NAVB News...

NAVB's Top Competitors

NAVB $1.61 (-6.94%)
Current stock: NAVB
$0.00 (0.00%)
Current stock:
MDT $73.41 (-2.46%)
Current stock: MDT
BAX $70.16 (-0.71%)
Current stock: BAX